Hillel Galitzer - Apr 28, 2025 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role: Chief Operating Officer
Signature: /s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol: ENTX
Transactions as of: Apr 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/30/2025, 04:22 PM
Previous filing: Apr 23, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENTX	Ordinary Shares, par value NIS 0.0000769 per share	Award	$0	+26.3K	+40.95%	$0.00	90.6K	Apr 28, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENTX	Stock Option (right to buy)	Award	$0	+100K		$0.00	100K	Apr 28, 2025	Ordinary Shares, par value NIS 0.0000769 per share	100K	$2.28	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025.
F2	The options vest over a three-year period with 33% of the options vesting on April 28, 2025, the first anniversary of the vesting commencement date, and the remaining options vesting ratably on a quarterly basis over the remaining three-year period.